H-1B Filings
5
Established sponsor. DOL labor condition applications on file.
Manufacturing NY DOL H-1B OSHA ITA
BACTOLAC PHARMACEUTICAL, Inc.: H-1B Sponsorship Profile
BACTOLAC PHARMACEUTICAL, Inc. in NY (Manufacturing) is a sponsorship-and-safety profile: 5 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
BACTOLAC PHARMACEUTICAL, Inc. (NY): · 5 H-1B LCAs at a $112,001 disclosed median · OSHA Grade C (DART 1.20)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, BACTOLAC PHARMACEUTICAL, Inc. in NY carries 5 H-1B wage filings on record, a $112,001 median wage (below the $124,488 national median), a middling C OSHA safety grade and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
- 5 H-1B LCAs
- $112,001 median wage
- Grade C OSHA
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #8,777 of 51,370 sponsors in this corpus (about the 80th percentile), and disclosed median wage sits at the 40th percentile of 272,125 credible H-1B wage rows.
- 80th pct
- H-1B filing rank
- 40th pct
- median wage rank
- 50%
- safer on DART than
- 14%
- cleaner WARN history than
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
D
Federal workforce composite
43/100
4 of 4 federal tracks · BACTOLAC PHARMACEUTICAL, Inc.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Sponsorship scale A-
5 H-1B LCAs
#8,777 of 51,370 sponsors · 80th percentile by volume (DOL OFLC)
Disclosed pay D
$112,001 median
40th percentile of 272,125 credible H-1B wage rows
Workplace safety C-
OSHA Grade C · DART 1.20
Safer than 50% of 214,554 employers with an OSHA ITA record
Layoff stability F
0 WARN notices
Cleaner WARN history than 14% of 304,376 tracked employers (state workforce agencies)
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
Median H-1B Salary
$112,001
Below national median. Across 5 disclosed positions
OSHA Safety Grade
Grade C · DART 1.20
Near industry average. vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where BACTOLAC PHARMACEUTICAL, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$112,001 Top 60% higher than 40% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | BACTOLAC PHARMACEUTICAL, Inc. | DOL OFLC / OSHA |
| Industry | Manufacturing | NAICS / DOL |
| State | NY | U.S. Federal Records |
| H-1B Filings | 5 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $112,001 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | C | OSHA ITA |
| OSHA DART Rate | 1.20 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
BACTOLAC PHARMACEUTICAL, Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in NY (Manufacturing). In this corpus, H-1B filing volume ranks #8,777 of 51,370 sponsors in this corpus (about the 80th percentile); disclosed median wage sits at the 40th percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 50% of 214,554 employers with an establishment injury record.
H-1B Salary Data
| Job Title | Median |
|---|---|
| Quality Assurance Chemist | $115,750 |
| Sr. Quality Control Chemist | $113,000 |
| Sr. Formulation Chemist | $112,001 |
| Regulatory Affairs Associate | $84,000 |
| Systems Engineer | $75,000 |
What the Data Says About BACTOLAC PHARMACEUTICAL, Inc.
Signature stat: WARN history
Even with zero WARN notices, BACTOLAC PHARMACEUTICAL, Inc. still sits in the bottom third for layoff cleanliness — other employers have equally quiet records.
Heavy H-1B sponsor
BACTOLAC PHARMACEUTICAL, Inc. in NY (Manufacturing) filed 5 H-1B labor condition applications at a $112,001 disclosed median — a top-tercile sponsorship footprint in this corpus.
Typical disclosed pay
A $112,001 disclosed median lands near the middle of the wage distribution (40th percentile vs $124,488 nationally).
Safety near sector average
DART 1.2 tracks close to the 1.1 sector average (Grade C).
OSHA Safety Record
Grade C DART Rate: 1.20 (same-NAICS-sector avg: 1.14)
This employer DART rate (lower is safer)
Same NAICS-sector average
BACTOLAC PHARMACEUTICAL, Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).
Total reported injuries on file: 11.
Where BACTOLAC PHARMACEUTICAL, Inc. sits
This employer among Manufacturing H-1B peers
Across the 201 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, BACTOLAC PHARMACEUTICAL, Inc. files more petitions than 0% of them and discloses a higher median wage than 10%, the selective, below-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (5 filings · $112,001 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 42; the brand marker is BACTOLAC PHARMACEUTICAL, Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
How BACTOLAC PHARMACEUTICAL, Inc. compares to Manufacturing peers
BACTOLAC PHARMACEUTICAL, Inc.'s nearest H-1B-filing peers in Manufacturing (home state NY). Each card links to that employer's federal-records profile.
BACTOLAC PHARMACEUTICAL, Inc.
5 H-1B filings
NVIDIA Corporation
1,989 H-1B filings
Intel Corporation
1,938 H-1B filings
Nationwide employers with similar H-1B volume or workplace injury rate
Two federal-records peer sets for BACTOLAC PHARMACEUTICAL, Inc., both outside NY so the neighborhoods are not the same-industry VsCard above.
Similar OSHA DART rate
Nearest injury-rate peers outside NY (DART 1.20 here).
- 1901, Inc. (WI) · DART 1.20
- 808 (TX) · DART 1.20
- Aablerts Integrated Piping System Americas (SC) · DART 1.20
- Accra-Pac, INC DBA Voyant Beauty (IN) · DART 1.20
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
What to check before working with BACTOLAC PHARMACEUTICAL, Inc.
For BACTOLAC PHARMACEUTICAL, Inc., read sponsorship pay (5 H-1B LCAs, median $112,001) next to the OSHA safety grade (C).
- H-1B median is $112,001 across 5 disclosed-wage positions (of 5 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers
- Safety grade C reflects a DART rate read against the Manufacturing average of 1.14 - a relative benchmark, not an absolute verdict. How grades work
BACTOLAC PHARMACEUTICAL, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Read with this employer
- NVIDIA Corporation (CA) - 1,989 H-1B filings in the same Manufacturing roster
- Intel Corporation (CA) - 1,938 H-1B filings in the same Manufacturing roster
- Tesla, Inc. (TX) - 1,868 H-1B filings in the same Manufacturing roster
- Interpreting safety grades - how BACTOLAC PHARMACEUTICAL, Inc.'s OSHA DART read is graded against its sector.
- H-1B salary negotiation - using disclosed wages like BACTOLAC PHARMACEUTICAL, Inc.'s when you negotiate.
- Compare employers - put BACTOLAC PHARMACEUTICAL, Inc. next to peers on pay, safety, and WARN.
- National H-1B & safety statistics - where BACTOLAC PHARMACEUTICAL, Inc.'s #8,777 placement sits in the full federal roster.
Retrieved and formatted by PlainEmployers.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Frequently Asked Questions
Where does BACTOLAC PHARMACEUTICAL, Inc.'s H-1B wage sit nationally?
Among 272,125 credible H-1B wage rows in this corpus, BACTOLAC PHARMACEUTICAL, Inc.'s disclosed median of $112,001 sits at the 40th percentile (below the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
How does BACTOLAC PHARMACEUTICAL, Inc.'s H-1B filing volume compare to other sponsors?
BACTOLAC PHARMACEUTICAL, Inc. has 5 H-1B filings on record, ranking #8,777 of 51,370 sponsors in this corpus (about the 80th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
What does BACTOLAC PHARMACEUTICAL, Inc.'s OSHA safety grade mean?
BACTOLAC PHARMACEUTICAL, Inc. carries Grade C from its establishment injury record (11 injuries on file; DART 1.20). That DART rate is safer than roughly 50% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.